About
Volker has 18 years of industry experience in protein engineering and drug discovery. He headed Genencor’s Protein Engineering department, where he invented combinatorial consensus mutagenesis, selection by micro-compartmentalization as well as mutator technology. In addition, he initiated and led a collaboration with Seattle Genetics, that focused on antibody-enzyme fusion proteins. Prior to his work on biotherapeutics, Volker led projects optimizing enzymes for industrial applications as well as microbes for metabolic pathway engineering. Volker received his Ph.D. from Leipzig University in 1986 for studies on protease catalyzed peptide synthesis. After postdoctoral studies at the Institute for Protein Research in Pushchino (Russia), he moved to the University of Göttingen where he developed a novel method for the production of peptides from recombinant peptide-multimers. After a postdoc with Bill Rutter at the University of California, San Francisco he joined Genencor in 1994. V
Position in the VCSift Database
- • 1 investors hold the Co-Founder, President, and CTO role in VCSift. Volker Schellenberger is one of them.
- • 931 investors are based in Palo Alto, California, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Palo Alto, US
Contact Information
Find more investors like Volker
Search Investors